Huntleys' Stock of the Week
Marketplace
Hexima Extends Human Disease Program
Monday November 16, 2009, 10:03 am

Original Announcement: Hexima Extends Human Disease Program

Hexima reported promising early stage results in its externally-funded human disease program. The program is still considered to be in the discovery stage at this time. The Company is encouraged by its initial findings and has determined to undertake the next stage of research, which will determine whether any of the molecules of interest progress into clinical trials over the next 2-3 years. The Board proposes to obtain funding in the order of $2m for this project.

More information about HXL.AX
  •   

    • Copyright © 2010 Yahoo! Pty Limited. All rights reserved.
    Advertise with Us - Privacy Policy - Terms of Service - Help